-
Machine Learning Model Comparison for Freezing of Gait Prediction in Advanced Parkinson’s Disease Patients
-
Machine Learning-Driven Exploration of Epigenetic Patterns in Huntington’s Disease: Understanding Histone Modification Dynamics
-
Magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy for disabling tremor secondary to multiple sclerosis.
-
Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude
-
Malignant Functional Movement Disorders in Children, Experience from a Tertiary Care Center
-
Managing Cognitive Decline in Vascular Dementia with Associated Parkinsonism
-
Manganese-induced Parkinsonism Vs Rotenone-induced Parkinsonism: Animal Life Matters!
-
Mapping Cholinergic Signaling in Parkinson Disease Using [18F]VAT
-
Mapping the distribution of neurotransmitters to resting-state functional connectivity in patients with Parkinson’s disease
-
Mapping the Efficacy Landscape: A Network Meta-Analysis of Pharmacological Interventions in Huntington’s Disease
-
Mapping the Landscape of Tourette Syndrome Research: A Bibliometric Analysis
-
Masticatory function evaluation methods in movement disorders
-
Matrix in the Classroom: Augmented Reality’s Role in the Transformation of Neuroanatomy Education
-
MDS Clinical Supportive Criteria for Parkinson’s Disease are Associated with α-Synuclein Seed Amplification Assay Status
-
MDS PD e-Diary – a New Patient-Centered Digital Tool for People with Parkinson’s Disease
-
MDSGene Update and Expansion: Clinical and Genetic Spectrum of LRRK2 Variants in Parkinson´s Disease
-
Measures of Mitochondrial Function in Serum across the Parkinson’s Disease Spectrum
-
Measuring Cortisol Levels in Persons with Huntington’s Disease
-
Measuring Motor Improvement with a Wearable Device in a Parkinson Disease Patient undergoing Subcutaneous Levodopa Carbidopa Infusion
-
Mechanical and thermal thresholds in the MPTP macaque model of Parkinson’s disease
-
Mechanism Study of Familial Cortical Myoclonic Tremor with Epilepsy Type 1 Caused by Pentanucleotide Repeat Expansion in the SAMD12 Gene
-
Medication Effects on Bradykinesia and Tremor in Parkinson’s Disease, Measured by Wearable Sensors
-
Medication Refractory Restless Legs Syndrome: Real-World Experience
-
Melatonin Modulates NLRP3 Inflammasome Activation through TLR2 to Protect Against Parkinson’s Disease
-
Meta-Analysis of Two Randomized Controlled Trials Assessing the Efficacy of Mesdopetam (IRL790) in Levodopa-Induced Dyskinesia in Parkinson’s Disease
-
Metabolic characteristics of brain network in patients with Parkinson’s disease after Deep brain stimulation
-
Metabolic Covariance Networks in Progressive Supranuclear Palsy Revealed by Spatial independent component analysis
-
Metabolic Progressive Subtypes in Progressive Supranuclear Palsy
-
Metabolic Regulators of Mitochondrial DNA Release in Cellular Models of PRKN-linked Parkinson’s Disease
-
MIBG Uptake in the Major Salivary Glands in Patients with Parkinson’s Disease and Dementia with Lewy Bodies
-
Microstructural Changes in the Inferior Tuberal Hypothalamus Correlate with Daytime Sleepiness in Lewy Body Disease
-
Mild Behavioral Impairment in Lewy body disease: a potential marker of phenoconversion and disease severity
-
Minimally Clinical Important Differences of Hemifacial Spasm Score-30 (HFS-30) and Hemifacial Spasm Score-7 (HFS-7) for Patients with Hemifacial spasm
-
Miniscope-based neural circuit profiling in freely behaving animals for preclinical therapeutic assessment
-
Misdiagnosing Movement Disorders on a Terciary Academic Center in the Caribbean: A Series of Cases
-
Misdiagnosis of Cognitive Impairment in Parkinson’s disease
-
Misinterpretation of Hypnagogic/hypnopompic Experiences as Hallucinations in Parkinson’s Disease
-
Mitigating The Impact Of Covid-19 On Parkinson’s Disease: Insights From Vaccination Strategies
-
Mitochondrial Complex I Brain Imaging in Parkinson’s Disease and Lewy Body Dementia
-
Mixed Brain Pathology in Neurodegenerative Parkinsonism and Dementia
-
Mixed Cerebellar Ataxia in a Patient with a Novel FAT2 Gene Variant Associated with SCA45
-
Model-Based Gait Outcomes to Track Parkinson’s Disease Progression ?
-
Modeling the Role of Parkinson’s Disease-Specific Factors in Depression and Anxiety: Findings from MEX-PD Cohort
-
Moderate-to-severe upper limb spasticity patterns in the elderly are improved following treatment with incobotulinumtoxinA: a pooled analysis
-
Moderators of aerobic exercise effects on motor symptoms in patients with Parkinson’s disease: a systematic review and meta-analysis
-
Modifiable factors associated with Huntington’s disease progression in presymptomatic participants: explained longitudinal machine learning modelling
-
Molecular Landscape of Gastrointestinal Dysfunctions in Parkinson’s Disease
-
Monitoring Progress: Use of the Behavioral Dyscontrol Scale-2 (BDS-2) in FXTAS (Fragile X-associated Tremor Ataxia Syndrome) Progression
-
Monopolar sensing improves the efficiency of DBS programming in Parkinson’s disease
-
Mood and Apathy Outcomes after STN or GPi DBS for Parkinson’s Disease: An Interim Report from the ADROIT NAPA Sub-study
-
Morphology and Functional Connectivity of the Basolateral Amygdala and Rapid Eye Movement Sleep Behavior Disorder
-
Mortality Rate, Cause of Death and Factors Associated with Mortality in Late Stage Parkinson’s Disease
-
Motion-robust high-resolution imaging of nigrosome-1 in Parkinson’s disease
-
Motor and Non-Motor Characteristics of Parkinson’s Disease in a Prevalent Population in Tanzania
-
Motor and Non-Motor Outcomes of Bemdaneprocel in People With Parkinson’s Disease: Results up to 24 Months From a Phase 1 Study
-
Motor and Quality of Life Outcomes of Deep Brain Stimulation for Pediatric Dystonia – CHILD-DBS Registry
-
Motor Impact of Fasting in Parkinson’s Disease Patients: An overview
-
Motor Onset of Parkinson’s disease: the proximal limbs are first
-
Motor Phenotype Changes over time in Parkinson’s Disease. A 5-year Follow-up Study
-
MOVE-PD: Mapping the Correlation of Sedentary behavior with Motor Symptoms in Parkinson’s Disease
-
Movement Disorder Presentations in Leukoenephalopathy with Calcifications and Cysts
-
Movement Disorder Society Unified Parkinson’s Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in Both On and Off States
-
Movement Disorders Associated with Infectious Encephalitis in Pediatric Patients
-
Movement Disorders in Anti-IGLON5 Antibody Disease
-
Movement Disorders in Autoimmune Encephalitis: A case series of 11 cases.
-
Movement disorders in Brain Sagging Syndrome- A Systematic Review
-
Movement Disorders in Cerebrotendinous Xanthomatosis
-
Movement Disorders In Children With Monoamine Neurotransmitter Disorders
-
Movement Disorders in De Novo Hyperglycemic Crisis: Insights from a Clinical Case Series
-
Movement disorders in patients with central nervous system tuberculosis: A systematic review
-
Movement Disorders in the Emergency:New Insights
-
Movement Disorders Knowledge Among Medical Professionals in Central Asia
-
Movement disorders secondary to neurocysticercosis: a case report from Bolivia
-
Movement-Related Potentials Recorded Using Cerebellar Deep Brain Stimulation Leads
-
MR-guided focused ultrasound for essential tremor: exploratory analysis comparing unilateral and staged, bilateral thalamotomy
-
MRgFUS thalamotomy for essential tremor: Lesion location and clinical outcomes
-
MRgFUS thalamotomy for tremor-predominant Parkinson´s disease: a single-center prospective study
-
MRI Predictive Marker of the Vestibular Galvanic Stimulation Effectiveness in the Postural Instability Treatment in Parkinson’s Disease.
-
MRI Visible Perivascular Spaces are Associated with Disease Duration and Severity in Parkinson’s Disease
-
Multicenter study of efficacy and safety of subcutaneous foslevodopa/foscarbidopa treatment initiation or switch from LD/CD intestinal gel
-
Multicentric Randomized Control Trial of Buspirone in Levodopa-Induced Dyskinesias
-
Multifaceted Challenges in Multisystem Atrophy Management: Medication Sensitivity, Emotional Lability, and Increased Fall Risk
-
Multiple System Atrophy in a Patient with Normal Pressure Hydrocephalus
-
Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease
-
Muscle co-contraction in people with Parkinson’s disease suffering from freezing of gait
-
Muscle mass, body fat mass, and nutrition in patients with Huntington´s Disease
-
Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real world practice
-
Mutation of the ATP5F1A gene associated with dystonia, spasticity, myoclonus, cognitive impairment and epilepsy – a rare case report of a patient
-
Myoclonus and Encephalitis as an Adverse Event of mRNA COVID-19 Vaccine
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.